O'Neill Gilmore Neil (CIK 1742084) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-04). Recent activity: Sell EDIT (5,124 shares), Sell EDIT (15,380 shares), Sell EDIT (5,394 shares), Sell EDIT (5,603 shares), Sell EDIT (5,592 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Editas Medicine, Inc. (EDIT) | CEO | Sell | 5,124 | $15,563 |
| 2026-06-05 | Editas Medicine, Inc. (EDIT) | CEO | Sell | 15,380 | $41,526 |
| 2026-03-04 | Editas Medicine, Inc. (EDIT) | CEO | Sell | 5,394 | $10,896 |
| 2025-12-04 | Editas Medicine, Inc. (EDIT) | CEO | Sell | 5,603 | $12,046 |
| 2025-09-04 | Editas Medicine, Inc. (EDIT) | CEO | Sell | 5,592 | $14,539 |
| 2025-06-04 | Editas Medicine, Inc. (EDIT) | CEO | Sell | 15,192 | $26,130 |
来源：SEC Form 4 申报文件 · 截至 2026-09-04